316 related articles for article (PubMed ID: 30987263)
1. Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment.
Terao T; Minami Y
Cells; 2019 Apr; 8(4):. PubMed ID: 30987263
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog Pathway Inhibitors: A New Therapeutic Class for the Treatment of Acute Myeloid Leukemia.
Jamieson C; Martinelli G; Papayannidis C; Cortes JE
Blood Cancer Discov; 2020 Sep; 1(2):134-145. PubMed ID: 34661144
[TBL] [Abstract][Full Text] [Related]
3. GLI3 repressor determines Hedgehog pathway activation and is required for response to SMO antagonist glasdegib in AML.
Chaudhry P; Singh M; Triche TJ; Guzman M; Merchant AA
Blood; 2017 Jun; 129(26):3465-3475. PubMed ID: 28487292
[TBL] [Abstract][Full Text] [Related]
4. Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia.
Shallis RM; Bewersdorf JP; Boddu PC; Zeidan AM
Expert Rev Anticancer Ther; 2019 Aug; 19(8):717-729. PubMed ID: 31422721
[No Abstract] [Full Text] [Related]
5. Acute myeloid leukemia - strategies and challenges for targeting oncogenic Hedgehog/GLI signaling.
Aberger F; Hutterer E; Sternberg C; Del Burgo PJ; Hartmann TN
Cell Commun Signal; 2017 Jan; 15(1):8. PubMed ID: 28122581
[TBL] [Abstract][Full Text] [Related]
6. Nonhematopoietic cells represent a more rational target of in vivo hedgehog signaling affecting normal or acute myeloid leukemia progenitors.
Boyd AL; Salci KR; Shapovalova Z; McIntyre BA; Bhatia M
Exp Hematol; 2013 Oct; 41(10):858-869.e4. PubMed ID: 23747997
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of Hedgehog inhibitors in acute myeloid leukemia and establishment of valid biomarkers].
Minami Y
Rinsho Ketsueki; 2019; 60(7):843-846. PubMed ID: 31391375
[TBL] [Abstract][Full Text] [Related]
8. NANOG Expression as a Responsive Biomarker during Treatment with Hedgehog Signal Inhibitor in Acute Myeloid Leukemia.
Kakiuchi S; Minami Y; Miyata Y; Mizutani Y; Goto H; Kawamoto S; Yakushijin K; Kurata K; Matsuoka H; Minami H
Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28245563
[TBL] [Abstract][Full Text] [Related]
9. Glasdegib for the treatment of acute myeloid leukemia.
Bruzzese A; Martino EA; Labanca C; Mendicino F; Lucia E; Olivito V; Fimognari F; Neri A; Morabito F; Vigna E; Gentile M
Expert Opin Pharmacother; 2023; 24(14):1537-1543. PubMed ID: 37392098
[TBL] [Abstract][Full Text] [Related]
10. The interplay of Patched, Smoothened and cholesterol in Hedgehog signaling.
Hu A; Song BL
Curr Opin Cell Biol; 2019 Dec; 61():31-38. PubMed ID: 31369952
[TBL] [Abstract][Full Text] [Related]
11. HDAC6 inhibition decreases leukemic stem cell expansion driven by Hedgehog hyperactivation by restoring primary ciliogenesis.
Pezzotta A; Gentile I; Genovese D; Totaro MG; Battaglia C; Leung AY; Fumagalli M; Parma M; Cazzaniga G; Fazio G; Alcalay M; Marozzi A; Pistocchi A
Pharmacol Res; 2022 Sep; 183():106378. PubMed ID: 35918044
[TBL] [Abstract][Full Text] [Related]
12. The BET bromodomain inhibitor ZEN-3365 targets the Hedgehog signaling pathway in acute myeloid leukemia.
Wellbrock J; Behrmann L; Muschhammer J; Modemann F; Khoury K; Brauneck F; Bokemeyer C; Campeau E; Fiedler W
Ann Hematol; 2021 Dec; 100(12):2933-2941. PubMed ID: 34333666
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog Signaling in Myeloid Malignancies.
Abraham A; Matsui W
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638372
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
Brechbiel J; Miller-Moslin K; Adjei AA
Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
[TBL] [Abstract][Full Text] [Related]
15. Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia.
Lim Y; Gondek L; Li L; Wang Q; Ma H; Chang E; Huso DL; Foerster S; Marchionni L; McGovern K; Watkins DN; Peacock CD; Levis M; Smith BD; Merchant AA; Small D; Matsui W
Sci Transl Med; 2015 Jun; 7(291):291ra96. PubMed ID: 26062848
[TBL] [Abstract][Full Text] [Related]
16. Targeting of the Hedgehog pathway in myeloid malignancies: still a worthy chase?
Khan AA; Harrison CN; McLornan DP
Br J Haematol; 2015 Aug; 170(3):323-35. PubMed ID: 25892100
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells.
Fukushima N; Minami Y; Kakiuchi S; Kuwatsuka Y; Hayakawa F; Jamieson C; Kiyoi H; Naoe T
Cancer Sci; 2016 Oct; 107(10):1422-1429. PubMed ID: 27461445
[TBL] [Abstract][Full Text] [Related]
18. Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells.
Kobune M; Takimoto R; Murase K; Iyama S; Sato T; Kikuchi S; Kawano Y; Miyanishi K; Sato Y; Niitsu Y; Kato J
Cancer Sci; 2009 May; 100(5):948-55. PubMed ID: 19245435
[TBL] [Abstract][Full Text] [Related]
19. Expression of Hedgehog Pathway Mediator GLI Represents a Negative Prognostic Marker in Human Acute Myeloid Leukemia and Its Inhibition Exerts Antileukemic Effects.
Wellbrock J; Latuske E; Köhler J; Wagner K; Stamm H; Vettorazzi E; Vohwinkel G; Klokow M; Uibeleisen R; Ehm P; Riecken K; Loges S; Thol F; Schubert C; Amling M; Jücker M; Bokemeyer C; Heuser M; Krauter J; Fiedler W
Clin Cancer Res; 2015 May; 21(10):2388-98. PubMed ID: 25745035
[TBL] [Abstract][Full Text] [Related]
20. Update on glasdegib in acute myeloid leukemia - broadening horizons of Hedgehog pathway inhibitors.
Fersing C; Mathias F
Acta Pharm; 2022 Mar; 72(1):9-34. PubMed ID: 36651529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
